Guide for Authors

  • All journal information and instructions compiled in one document (PDF) in just one mouse-click Author information pack

    INTRODUCTION
    • Aims and Scope
    • Category of Articles
    BEFORE YOU BEGIN
    • Ethics in publishing
    • Conflict of interest
    • Submission declaration
    • Authorship
    • Changes to authorship
    • Copyright
    • Role of the funding source
    • Funding body agreements and policies
    • Open access
    • Language (usage and editing services)
    • Submission
    PREPARATION
    • Double-blind review
    • Use of word processing software
    • Article structure
    • Essential title page information
    • Structured abstract
    • Keywords
    • Acknowledgements
    • Units
    • Math formulae
    • Footnotes
    • Artwork
    • Illustration services
    • References
    • Supplementary data
    AFTER ACCEPTANCE
    • Use of the Digital Object Identifier
    • Proofs
    • Offprints
    AUTHOR INQUIRIES

    Aims and Scope

    Medical Dosimetry aims to publish articles that will enhance the overall knowledge of the medical dosimetrist. Articles are published from the point of view not only of dosimetrists, but also of medical physicists, radiation oncologists, radiologic technologists, and other specialists. Therefore, submissions to Medical Dosimetry must concern subject matter relevant to the common field of medical dosimetry. Content should add to or improve the working knowledge of a medical dosimetrist or to the field of radiation oncology in general. Articles that do not meet these requirements will be deemed out of scope and returned without review.

    Maintenance of Profile

    It is the responsibility of the Author to assure all contact and personal information is current in his/her user profile. Medical Dosimetry will not assume responsibility for obtaining updated contact information for any Author. Manuscripts for which the listed Corresponding Author's information is invalid will be automatically assigned a status of "withdrawn." Failure to maintain user profiles may result in rejection of the manuscript, even after an acceptance has been issued, when a communication pathway for correspondence with the journal is required and determined by the Editor-in-Chief to be unavailable.

    Category of Articles

    1. Articles Category:
    a. Dosimetry Contribution
    b. Medical Physics Contribution
    c. Clinical Radiation Oncology Contribution

    It is recognized that radiation oncology is a specialty that uniquely integrates different professional aspects. As such, it is natural that many manuscripts will incorporate elements of each of the former categories. Therefore, the Corresponding Author should identify the predominant theme of the manuscript and submit it under that category.

    Dosimetry Contribution: The theme of an article submitted as a Dosimetry Contribution should indicate how theory is translated into practical implementation for use by the medical dosimetrist.
    Examples:

    • use of treatment planning involved in the research process
    • how new technology can be incorporated into practical treatment delivery or planning
    • implementation and use of new techniques

    Medical Physics Contribution: The theme of an article submitted as a Medical Physics Contribution should predominantly address radiation oncology related physics theory, quality assurance, and/or subject matter that pertains to the function of a medical physicist working in radiation oncology.
    Examples:

    • machine or beam characteristics
    • algorithm development or their implementation
    • analysis of models (physical or biological)
    • quality assurance mechanics, control practices, or techniques

    Clinical Radiation Oncology Contribution: The theme of an article submitted as a Clinical Contribution should predominantly address how a class of patients responds to a particular treatment or technique.
    Examples:

    • use of tumor dose limits for better tumor treatment
    • biological motivation or changes in outcomes due to the use of new treatment or simulation approaches
    • dose-related response characteristics


    2. Article Type Submissions may be in the form of a (a) Research Article, (b) Review Article, (c) Case Study, (d) Technical Note, (e) Didactic Note, or (f) Letter to the Editor. For length estimation, a rule of thumb is to divide the double-spaced manuscript text by 3 and the number of figures/tables by 4 to estimate the total count of resulting printed pages.

    a. A Research Article is a report of original experimental or theoretical research. Authors should keep in mind that attention to clarity and conciseness facilitates the review process and also the impact of the published article. Limit: 10 journal pages.
    b. A Review Article is an authoritative review of a subject important to the field of radiation oncology. It may be either invited or proffered. In either case, the review process will be employed. Limit: 10 journal pages.
    c. A Case Study is a concise description of a technique, procedure, clinical implementation, or clinical patient-related complication of relevance to the practice of medical dosimetry. Appropriate for this article type are "tricks-of-the-trade," helpful hints to solve a specific problem, or "how-tos" on application to clinical practice. Limit: 3 journal pages.
    d. A Technical Note is a brief description of a specific new development, procedure, or use of a device that offers a solution to a current specific problem and has sufficient relevance to be useful to many readers of Medical Dosimetry. Limit: 3 journal pages.
    e. A Didactic Note is a short explanation of technical or clinical concepts that are specifically relevant to the practice and understanding of medical dosimetry. The Didactic Note may still present some newly measured data or a new derivation of some kind, but this must be done with pedagogic purpose in mind. These submissions should contain a brief introduction that explains why clarification of the topic is necessary. Limit: 4 journal pages.
    f. A Letter to the Editor is a brief response to a published article of general interest to readers. It may be either invited or proffered. Letter must reference Medical Dosimetry articles no older than two issues from the last published volume. Limit: 1 journal page.

    Ethics in publishing

    For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.

    Conflict of interest

    All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See also http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://help.elsevier.com/app/answers/detail/a_id/286/p/7923.

    Submission declaration

    Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/postingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

    Prior Publication

    The submission of a manuscript with the exact same words or general premises as that of another published article is plagiarism. Authors do not have the right under any circumstances to try to double-publish any information or phrasing whatsoever in an article submitted to Medical Dosimetry. Although it is rare, such acts have been identified within the journal on different levels. The most common motive behind these types of publications involves academic advancement by increasing their professional productivity (Benos DJ, Fabres J, Farmer J, et al. Ethics and scientific publication. Advan Physiol Edu 2005;29:59-74). Authors are strongly recommended to review the types of plagiarism below, to become familiar with unacceptable practice histories, in order to avoid actions taken by the journal or through copyright litigation from other authors or researchers.
    Often, plagiarism is identified on a minor level where the occurrence is when the authors were found to plagiarize words from their own prior published works. Regardless of whether or not the two articles are from the same author(s), it is an unacceptable practice occurrence. Plagiarism also comes in the form of inadequate referencing or quoting the conclusions of published papers without a link to authorship. This is a more common situation. However, it is a more serious problem for the author, because it involves other authors with copyright protected publications already in press. From this standpoint, the issue is less of a conflict professionally if it is caught during the review or editing process, because it would not have been published yet. Given the possibility of an article submission to take on a form of redundancy (repetitive ideas of the same author), duplication (double-publishing) or plagiarism (copying), such instances may result in swift and direct action, possibly prohibition from further submissions to the Journal altogether.
    Medical Dosimetry and the AAMD do not tolerate plagiarism or any misrepresentation of original work. Authors found in violation of this position will be barred from further submissions to the Journal. This is a risk for not only the Corresponding Author, but to all other Co-authors on the identified manuscript as well.

    Authorship

    All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

    Rights of Co-Authors

    Even though persons may have been a part of a research endeavor, they may not attest to the data being transmitted into the scientific mainstream with their name attached to it. Conversely, if the researcher was a major part of the work conducted, there should be consideration to include them as an author of the manuscript or in the Acknowledgements section. These two possibilities are to be decided upon by the Corresponding Author, who is solely responsible for every component of the manuscript submitted. The Journal does not endorse or protect authors from failure to comply with copyright laws or litigation related to publication and research credit.

    The Corresponding Author shall always provide ample time for Co-authors to discuss and edit the manuscript both prior to initial submission, after every revision required, and throughout publication production processes. It is recommended that complete communication be provided to each co-author. This includes updates on submission review status and comments from the Associate Editor and/or Reviewers.

    All correspondence is to be carried solely by the Corresponding Author. The Corresponding Author is responsible for ensuring that all individuals included as Co-authors have: (1) made substantial contributions to conception and design, and/or acquisition of data, and/or analysis, and/or interpretation of data; (2) drafted the article and/or revised it critically for important intellectual content, and (3) given final approval of the version to be published. All Co-authors should meet conditions (1), (2) and (3). The Corresponding Author is also responsible for ensuring that no legitimate Co-authors have been omitted. For submissions where the first author of a paper is a student or fellow, the Corresponding Author should be an experienced scientist with supervisory responsibilities.

    Corresponding Author are responsible for ensuring that manuscripts are written in clear English. For a list of companies that can offer language editing services, please see http://www.elsevier.com/languagepolishing. If English is not the first language of the Corresponding Author, he or she should seek help from a colleague for whom English is the first language to review and edit the paper before its initial submission. Articles that do not strictly adhere to the submission guidelines and format will be returned without review.

    The word "significant" should be used in a manuscript only in a statistical context and should be accompanied by the results of a statistical analysis. It should not be used as a modifying adjective. As specified below, for specific article types, it may be necessary to explain the use of statistics in more detail than usual.

    Changes to authorship

    This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
    Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
    After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

    Copyright

    This journal offers authors a choice in publishing their research: Open access and Subscription.

    For subscription articles
    Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see http://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
    Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.

    For open access articles
    Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (for more information see http://www.elsevier.com/OAauthoragreement). Permitted reuse of open access articles is determined by the author's choice of user license (see http://www.elsevier.com/openaccesslicenses).

    Retained author rights
    As an author you (or your employer or institution) retain certain rights. For more information on author rights for:
    Subscription articles please see http://www.elsevier.com/journal-authors/author-rights-and-responsibilities.
    Open access articles please see http://www.elsevier.com/OAauthoragreement.

    Role of the funding source

    You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

    Funding body agreements and policies

    Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.

    Open access

    This journal offers authors a choice in publishing their research:

    Open access
    • Articles are freely available to both subscribers and the wider public with permitted reuse
    • An open access publication fee is payable by authors or their research funder
    Subscription
    • Articles are made available to subscribers as well as developing countries and patient groups through our access programs (http://www.elsevier.com/access)
    • No open access publication fee

    All articles published open access will be immediately and permanently free for everyone to read and download. Permitted reuse is defined by your choice of one of the following Creative Commons user licenses:
    Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY-NC-SA).
    Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

    Elsevier has established agreements with funding bodies, http://www.elsevier.com/fundingbodies. This ensures authors can comply with funding body open access requirements, including specific user licenses, such as CC BY. Some authors may also be reimbursed for associated publication fees. If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication.

    To provide open access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published open access.
    Your publication choice will have no effect on the peer review process or acceptance of submitted articles.

    The open access publication fee for this journal is $2,500, excluding taxes. Learn more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing.

    Language (usage and editing services)

    Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our customer support site (http://support.elsevier.com) for more information.

    Submission

    Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.

    Submit your article
    Please submit your article via http://ees.elsevier.com/meddos.

    When a revision is called for, Corresponding Authors will have three (3) months within which to submit their revision. If a revision is not submitted, the submission will be archived and rejected without further processing. For all revisions, the manuscript will be assigned a new manuscript number and considered as a new submission to the Journal. It is likely that the same Associate Editor and Reviewers will handle the revision(s).



    Style: Authors are expected to follow the conventional writing, notation, and illustration style prescribed in the American Institute of Physics (AIP) Style Manual. A free copy is available by clicking on the link provided (http://www.aip.org/pubservs/style/4thed/toc.html ). Authors are encouraged to gain familiarization with the journal's form and style by reviewing recent issues of Medical Dosimetry. The order of information should be provided as follows: title with the first word capitalized, authors' names, authors' affiliations, abstract, text, acknowledgments, appendixes (if necessary), collected references in the order in which they are cited, tables each with a caption, collected figure captions, and figures. Some additional highlights are summarized below.

    Double-blind review

    This journal uses double-blind review, which means that both the reviewer and author name(s) are not allowed to be revealed to one another for a manuscript under review. The identities of the authors are concealed from the reviewers, and vice versa. For more information please refer to http://www.elsevier.com/reviewers/peer-review. To facilitate this, please include the following separately:
    Title page (with author details): This should include the title, authors' names and affiliations, and a complete address for the corresponding author including telephone and e-mail address.
    Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and any Acknowledgements) should not include any identifying information, such as the authors' names or affiliations.

    Manuscripts are normally reviewed by an Associate Editor and by one or more independent Reviewers chosen by the Associate Editor. Upon submission, the Editor-in-Chief and/or Associate Editor will determine whether the topic is relevant and should proceed through the review process. The Associate Editor will determine whether the article is appropriate for the category as stated by the Corresponding Author. The article may be rejected at this point or returned to the Corresponding Author with suggestions on how it would be more appropriate for a category and type. Reviewer comments are requested to be both general and specific. It is important for the Corresponding Author to respond to each specific comment or suggestion in an itemized fashion after apprising all Co-authors of the communications from the journal office.

    Use of word processing software

    It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
    To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

    Embedded math equations
    If you are submitting an article prepared with Microsoft Word containing embedded math equations then please read this related support information (http://support.elsevier.com/app/answers/detail/a_id/302/).

    Article structure

    Subdivision - unnumbered sections
    Divide your article into clearly defined sections. Each subsection is given a brief heading. Each heading should appear on its own separate line. Subsections should be used as much as possible when cross-referencing text: refer to the subsection by heading as opposed to simply 'the text'.

    Introduction
    State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

    Material and methods
    Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.

    Results
    Results should be clear and concise.

    Discussion
    This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.

    Conclusions
    The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.

    Appendices
    If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.

    Essential title page information

    Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
    Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
    Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
    Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

    Structured abstract

    A structured abstract, by means of appropriate headings, should provide the context or background for the research and should state its purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations.

    Keywords

    Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.

    Acknowledgements

    Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

    Units

    Follow internationally accepted rules and conventions: use the international system of units (SI). If other units are mentioned, please give their equivalent in SI.

    Math formulae

    Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).

    Embedded math equations
    If you are submitting an article prepared with Microsoft Word containing embedded math equations then please read this related support information (http://support.elsevier.com/app/answers/detail/a_id/302/).

    Footnotes

    Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.

    Artwork

    Electronic artwork
    General points
    • Make sure you use uniform lettering and sizing of your original artwork.
    • Embed the used fonts if the application provides that option.
    • Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
    • Number the illustrations according to their sequence in the text.
    • Use a logical naming convention for your artwork files.
    • Provide captions to illustrations separately.
    • Size the illustrations close to the desired dimensions of the printed version.
    • Submit each illustration as a separate file.
    A detailed guide on electronic artwork is available on our website:
    http://www.elsevier.com/artworkinstructions
    You are urged to visit this site; some excerpts from the detailed information are given here.
    Formats
    If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
    Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
    EPS (or PDF): Vector drawings, embed all used fonts.
    TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
    TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
    TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
    Please do not:
    • Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
    • Supply files that are too low in resolution;
    • Submit graphics that are disproportionately large for the content.

    Color artwork
    Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
    Please note: Because of technical complications that can arise by converting color figures to 'gray scale' (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.

    Illustration services

    Elsevier's WebShop (http://webshop.elsevier.com/illustrationservices) offers Illustration Services to authors preparing to submit a manuscript but concerned about the quality of the images accompanying their article. Elsevier's expert illustrators can produce scientific, technical and medical-style images, as well as a full range of charts, tables and graphs. Image 'polishing' is also available, where our illustrators take your image(s) and improve them to a professional standard. Please visit the website to find out more.

    Figure captions
    Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.

    Tables: Extensive numerical material should be presented in tables rather than in the body of the text. Each table must have a caption that makes the data in the table intelligible without reference to the text. Complicated column headings should be avoided, but symbols used in the tables should be in the caption. Long tables should be avoided if possible. Footnotes to tables should be indicated by lower case letters in the following order: *,†, ‡, #, ∥, §, **. Tables should not include extensive detail that could be included in the main manuscript. Tables should be numbered using Arabic numerals starting from 1.

    References

    Citation in text
    Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.

    Reference links
    Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is encouraged.

    Web references
    As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

    Reference style
    References should be assigned consecutive numbers as they occur in the body of the text. They should also be listed in the same order on a separate sheet. Titles of articles, complete lists of authors, and inclusive pagination must be included. References must be in the accessible, archival literature. Private communications and commercial identifications and manuals are not appropriate for the reference list, but can be identified as parenthetical references within the text. A minimum of 10 references should be cited for all submissions with the exception of Case Reports, Technical Notes, and Letters to the Editor. For these two, no more than 10 references are permitted. References should be submitted in the following formats:

    Journal:
    1. Ling, C.C.; Spiro, I.J.; Mitchell, J.; Stickler, R. The variation of OER with dose rate. Int. J. Radiat. Oncol. Biol. Phys. 11:1367-1373; 1985.

    Book:
    2. Bentel, G.C.; Nelson, C.E.; Noel, K.T. Treatment planning and dose calculation in radiation oncology. 3d ed. Elmsford, NY: Pergamon Press; 1986.

    Chapter in Edited Book:
    3. Marks, J.E.; Lee, F. Irradiation techniques for head and neck cancer. In: Levitt, S.H.; Tapley, N.V., editors. Technological basis of radiation therapy: practical clinical applications. Philadelphia: Lea and Febinger; 1984:116-119.

    Journal abbreviations source
    Journal names should be abbreviated according to the List of Title Word Abbreviations: http://www.issn.org/services/online-services/access-to-the-ltwa/.

    Supplementary data

    Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.

    The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
    Ensure that the following items are present:
    One author has been designated as the corresponding author with contact details:
    • E-mail address
    • Full postal address
    • Phone numbers
    All necessary files have been uploaded, and contain:
    • Keywords
    • All figure captions
    • All tables (including title, description, footnotes)
    Further considerations
    • Manuscript has been 'spell-checked' and 'grammar-checked'
    • References are in the correct format for this journal
    • All references mentioned in the Reference list are cited in the text, and vice versa
    • If the paper was presented at a meeting, the name of the organization, place, and date of the meeting should be listed.
    • Permission has been obtained for use of copyrighted material from other sources (including the Web)
    • Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-white in print
    • If only color on the Web is required, black-and-white versions of the figures are also supplied for printing purposes
    • Manuscript has been blinded to authors' identity.
    For any further information please visit our customer support site at http://support.elsevier.com.

    Permissions
    If a table or figure has been previously published, the manuscript should include a credit line and the Corresponding Author should include a permission letter from the original publisher.

    Use of the Digital Object Identifier

    The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
    http://dx.doi.org/10.1016/j.physletb.2010.09.059
    When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

    Proofs

    One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 9 (or higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/reader/tech-specs.html.
    If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.

    Offprints

    The corresponding author, at no cost, will be provided with 25 free paper offprints, or, alternatively, a personalized link providing 50 days free access to the final published version of the article on ScienceDirect. This link can also be used for sharing via email and social networks. For an extra charge, more paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover (http://webshop.elsevier.com/myarticleservices/booklets).



    You can track your submitted article at http://help.elsevier.com/app/answers/detail/a_id/89/p/8045/. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support.elsevier.com.

Advertisement

advert image